首页> 外文会议>Annual Meeting of the Japanese Association for Animal Cell Technology >Analysis of immunosuppressive factors expressed in serum of liver transplanted rats
【24h】

Analysis of immunosuppressive factors expressed in serum of liver transplanted rats

机译:肝移植大鼠血清中表达的免疫抑制因子分析

获取原文
获取外文期刊封面目录资料

摘要

Administration of immunosuppressant is essendal for successful organ transplantation, but includes problems such as long-term medication or serious side effect. It is therefore preferable to develop a new effective immunosuppressant. In the rat model of liver transplantation, it has been known that DA livers transplanted to PVG recipients are accepted without the treatment of immunosuppressa. It has also been demonstrated that PVG recipient serum after orthotopic liver transplantation (post-OLT serum) shows in vivo immunosuppressive activity. However, the mechanism underlying such a drug-free tolerance is still unclear. Here, we characterized immunosuppressive factors expressed in post-OLT serum through evaluating immunosuppressive effect in vitro. We found that post-OLT sera possessed significant mixed lymphocyte reaction (MLR)-inhibitory activity. Since IgG level remarkably increased in post-OLT sera, we examined the role of IgG in the MLR suppression. We found that IgG depletion abrogated MLRinhibitory effect, and that purified post-OLT serum IgG suppressed MLR, suggesting that IgG antibodies are important MLR-inhibitory factor in the post-OLT serum. We next tested whether the IgG antibodies recognized specific antigen in PVG splenocytes. Western blot analysis demonstrated that three antigens (73, 34, and 31kD) were specifically recognized by post-OLT serum IgG in the early phase (7 to 21 days). Furthermore, immunodepletion of specific antibodies against these antigens abolished the MLR-inhibitory activity, suggesting that MLR-suppressive action of post-OLT IgG is mediated via recognition of these antigens.
机译:免疫抑制剂的给药是成功器官移植的展示,但包括长期药物或严重副作用等问题。因此,优选开发一种新的有效免疫抑制剂。在肝移植的大鼠模型中,已知移植到PVG接受者的DA肝脏而不会治疗免疫抑制剂。还证实了在肝脏移植(后OLT血清后OLT血清后血清后的PVG受体血清,所述免疫抑制活性显示。然而,这种无毒耐受性的机制仍然不清楚。在这里,我们通过在体外评估免疫抑制作用来表征在OLT后血清中表达的免疫抑制因子。我们发现,OLT后血清具有显着的混合淋巴细胞反应(MLR)抑制活性。由于后OLT血清中IgG水平显着增加,因此我们检查了IgG在MLR抑制中的作用。我们发现IgG耗尽废除MLRINUCHION效应,并且纯化的后OLT血清IgG抑制的MLR,表明IgG抗体是后OLT血清中重要的MLR抑制因子。接下来测试IgG抗体是否识别PVG脾细胞中的特异性抗原。 Western印迹分析表明,在早期阶段(7至21天)的OLT血清IgG特异性地识别出三种抗原(73,34和31kd)。此外,对这些抗原的特异性抗体的免疫成分废除了MLR抑制活性,表明在OLT IgG后的MLR抑制作用通过识别这些抗原介导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号